Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 trial of ARX788 in HER2-positive advanced gastric patients who have been previously treated

Trial Profile

A Phase 1 trial of ARX788 in HER2-positive advanced gastric patients who have been previously treated

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 07 Oct 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ARX 788 (Primary)
  • Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
  • Focus Adverse reactions
  • Acronyms ACE-Gastric-01
  • Sponsors Ambrx
  • Most Recent Events

    • 04 Oct 2021 According to an Ambrx media release, trial has completed the enrollment of 30 patients.
    • 04 Oct 2021 Positive interim data from this trial were presented at The Chinese Society of Clinical Oncology (CSCO).
    • 04 Oct 2021 Positive interim data (data as of June 30, 2021) published in an Ambrx Media Release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top